Results 51 to 60 of about 5,791,370 (216)
Invasive meningococcal disease in children in Jerusalem
SUMMARYNeisseria meningitidisis an important cause of childhood meningitis and septicaemia. Between 1999 and 2005, 133 invasive meningococcal disease (IMD) cases occurred in Jerusalem, 112 (84·2%) of them in children aged 0–14 years. The annual incidence rate in Jerusalem was higher than the national average (2·45±0·6vs.
C, Stein-Zamir +5 more
openaire +3 more sources
Expanding prevention of invasive meningococcal disease
Invasive meningococcal disease due to serogroups A, C, Y and W-135 is a serious, vaccine-preventable, worldwide public-health problem. Despite early treatment and advances in medical care, morbidity and mortality rates have essentially remained unchanged.
Stephen I, Pelton, Gregory P, Gilmet
openaire +2 more sources
Social Behavior and Meningococcal Carriage in British Teenagers
Understanding predisposing factors for meningococcal carriage may identify targets for public health interventions. Before mass vaccination with meningococcal group C conjugate vaccine began in autumn 1999, we took pharyngeal swabs from ?14,000 UK ...
MacLennan, J. +43 more
core +2 more sources
Molecular epidemiology of meningococcal disease in Northern Ghana [PDF]
Meningococcal disease remains a major public health concern, especially in the African Meningitis Belt where large meningitis epidemics with attack rates of up to 500/100,000 recur every 8-12 years.
Gagneux, Sébastien
core +1 more source
Self Mutilating Behaviour in Severe Meningococcal Infection; An Interesting Association [PDF]
Neisseria meningitidis most commonly manifests as asymptomatic colonization in the nasopharynx of healthy adolescents and adults. It may rarely present as invasive disease which may be either bacterial meningitis or meningococcal septicaemia.
Anju Dinkar +4 more
doaj +1 more source
Carriage of Neisseria meningitidis, the meningococcus, is a prerequisite for invasive meningococcal disease (IMD), a potentially devastating infection that disproportionately afflicts infants and children.
Holly B. Bratcher +15 more
doaj +1 more source
Background: Trumenba™, a bivalent, factor-H binding protein meningococcal serogroup B (MenB-fHBP) vaccine was authorized for use in Canada in October 2017 for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis ...
Robyn Harrison +3 more
doaj +1 more source
Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?
In this era of new pneumococcal conjugate vaccines (PCV), we described and compared surveillance of invasive pneumococcal disease (IPD) and PCV policies in 30 European countries to provide guidance for Europe-wide surveillance.
Perrocheau, Anne +44 more
core +1 more source
Current safety issues with quadrivalent meningococcal conjugate vaccines
Invasive meningococcal disease, although rare, can present as sudden, life-threatening disease with high risk of mortality or severe long-term sequelae.
Tanya R. Myers, Michael M. McNeil
doaj +1 more source
Meningococcal infection is an acute infectious disease caused by Neisseria meningitidis, characterized by a polymorphism of clinical manifestations from meningococcus carriage to invasive forms.
V. V. Sharabkhanov +12 more
doaj +1 more source

